Search For "generic"
India 'pharmacy of the world', on fast-track mode to develop COVID-19 vacc
Updated : 5 years, 10 months ago IST
New Delhi [India], July 14 (ANI): India is considered as the "pharmacy of the world". About 60 per cent of the drugs uitilised in the United States of America are of Indian origin. So, these are generic drugs produced in India where the country has established itself over the years. This is
Read More
Mangal Keshav Securities Limited gives Buy Call on Generic Engineering Con
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], July 13 (ANI/NewsVoir): Mangal Keshav Securities Limited has given a Buy Call on BSE listed Generic Engineering Constructions and Projects Ltd. (GECPL) with a target price of Rs 106.
Read More
Indian pharma compliance standards improving, regulatory risks here to sta
Updated : 5 years, 11 months ago IST
Mumbai (Maharashtra) [India], July 7 (ANI): Indian pharmaceutical companies have built a strong abbreviated new drug application (ANDA) pipeline since FY12 through scaling-up of investments in R&D but this will increase the inspection intensity, India Ratings and Research (Ind-Ra) said o
Read More
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per via
Updated : 5 years, 11 months ago IST
Bengaluru (Karnataka) [India], July 7 (ANI): Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI) and will launch a generic version of Gilead Sciences' COVID-19 anti-viral in the country at Rs 4,800 for 100 mg/vial.
Read More
COVID-19: States being delivered generic version of Remdesivir, 20 thousan
Updated : 5 years, 11 months ago IST
New Delhi [India], June 25 (ANI): Domestic pharma giant Hetero has started delivering the generic version of 20,000 vials of Covifor (Remdesivir) across the country. The product is priced at Rs 5,400/- per vial.
Read More
Biocon, DKSH collaborate to commercialise 7 generic formulations in SE Asi
Updated : 5 years, 11 months ago IST
Bengaluru (Karnataka) [India], June 22 (ANI): Biopharmaceutical major Biocon Ltd and Swiss market expansion services group Diethelm Keller Siber Hegner (DKSH) said on Monday their subsidiaries have signed an agreement under which DKSH will sell and distribute seven of Biocon Pharma's generic
Read More
Dr Reddy's completes acquisition of Wockhardt's select business divisions
Updated : 5 years, 12 months ago IST
Hyderabad (Telangana) [India], June 10 (ANI): Dr Reddy's Laboratories said on Wednesday it has completed the acquisition of select divisions of Wockhardt Ltd's branded generics business in India and a few other international territories of Nepal, Sri Lanka, Bhutan and Maldives.
Read More
Pharmacy and Biotechnology students of Chandigarh University gets placed i
Updated : 6 years ago IST
Chandigarh [India], May 26 (ANI/PRNewswire): With India ranking third globally in the production of medicines and largest producer of generic medicines, the pharmaceutical sector of the country has grown in leaps and bounds during the last two decades.
Read More
Gilead in talks with Indian drugmakers to produce remdesivir for treatment
Updated : 6 years, 1 month ago IST
New Delhi [India], May 6 (ANI): US-based biopharmaceutical major Gilead Sciences said on Wednesday it is negotiating long-term voluntary licences with several generic drugmakers in India to produce remdesivir for developing countries.
Read More
17-Year entrepreneur Arjun Deshpande contributes 3-months salary to PM Car
Updated : 6 years, 2 months ago IST
New Delhi [India], April 3 (ANI/ Digpu): Arjun Deshpande, Founder and CEO of Generic Aadhaar, an innovative venture in the Pharmaceutical Industry has donated his three-months' salary to PM Cares Fund. He made this contribution to be a force multiplier in the fight against COVID-19.
Read More
Aurobindo Pharma's $1 billion deal with Novartis unit Sandoz collapses
Updated : 6 years, 2 months ago IST
Hyderabad (Telangana) [India], Apr 2 (ANI): Aurobindo Pharma's planned acquisition of the US generic oral solids and dermatology businesses of Sandoz Inc has fallen apart.
Read More
Intas contributes for the global trials against COVID-19
Updated : 6 years, 2 months ago IST
Ahmedabad (Gujarat) [India], Mar 30 (ANI/ PRNewswire): Intas Pharmaceuticals Ltd., the largest supplier by volume of generic medicines to the UK NHS, is collaborating on a World Health Organisation endorsed study into the prevention of COVID-19 infection using hydroxychloroquine, a drug t
Read More